Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/21 17:00 | 11/15/21 | ALNA | Health | BioPrd | Biological Products, (No Diag | Brenner Louis Md | MA | DO | P,CEO | S.d | -33 | 0.8100 | 0 | -40 | -11 | 329 | D | ||||||||||||||
5/12/21 16:45 | 5/10/21 | ALNA | Health | BioPrd | Biological Products, (No Diag | Brenner Louis Md | MA | O | P,COO | S.d | -28 | 1.11 | 0 | -25 | -10 | 229 | D | ||||||||||||||
12/18/20 16:15 | 12/17/20 | ALNA | Health | BioPrd | Biological Products, (No Diag | Wholihan Edward | MA | O | CFO | S.d | -93 | 1.36 | 0 | -69 | -27 | 190 | D | ||||||||||||||
12/18/20 16:15 | 12/17/20 | ALNA | Health | BioPrd | Biological Products, (No Diag | Brenner Louis Md | MA | O | P,CEO | S.d | -140 | 1.36 | 0 | -103 | -29 | 248 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |